These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report. Lou Y, Lv Y, Yu J, Gu W, Jiang M, Chen J. BMC Med Genomics; 2024 Jul 16; 17(1):187. PubMed ID: 39014344 [Abstract] [Full Text] [Related]
26. Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms. Pazmandi J, Kalinichenko A, Ardy RC, Boztug K. Immunol Rev; 2019 Jan 16; 287(1):162-185. PubMed ID: 30565237 [Abstract] [Full Text] [Related]
27. Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity. Hall CHT, de Zoeten EF. Immunol Rev; 2024 Mar 16; 322(1):329-338. PubMed ID: 38115672 [Abstract] [Full Text] [Related]
28. Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study. Charbit-Henrion F, Parlato M, Hanein S, Duclaux-Loras R, Nowak J, Begue B, Rakotobe S, Bruneau J, Fourrage C, Alibeu O, Rieux-Laucat F, Lévy E, Stolzenberg MC, Mazerolles F, Latour S, Lenoir C, Fischer A, Picard C, Aloi M, Dias JA, Hariz MB, Bourrier A, Breuer C, Breton A, Bronsky J, Buderus S, Cananzi M, Coopman S, Crémilleux C, Dabadie A, Dumant-Forest C, Gurkan OE, Fabre A, Fischer A, Diaz MG, Gonzalez-Lama Y, Goulet O, Guariso G, Gurcan N, Homan M, Hugot JP, Jeziorski E, Karanika E, Lachaux A, Lewindon P, Lima R, Magro F, Major J, Malamut G, Mas E, Mattyus I, Mearin LM, Melek J, Navas-Lopez VM, Paerregaard A, Pelatan C, Pigneur B, Pais IP, Rebeuh J, Romano C, Siala N, Strisciuglio C, Tempia-Caliera M, Tounian P, Turner D, Urbonas V, Willot S, Ruemmele FM, Cerf-Bensussan N. J Crohns Colitis; 2018 Aug 29; 12(9):1104-1112. PubMed ID: 29788237 [Abstract] [Full Text] [Related]
29. Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey. Huang Z, Peng K, Li X, Zhao R, You J, Cheng X, Wang Z, Wang Y, Wu B, Wang H, Zeng H, Yu Z, Zheng C, Wang Y, Huang Y. Inflamm Bowel Dis; 2017 Apr 29; 23(4):578-590. PubMed ID: 28267044 [Abstract] [Full Text] [Related]
31. Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study. Suzuki T, Sasahara Y, Kikuchi A, Kakuta H, Kashiwabara T, Ishige T, Nakayama Y, Tanaka M, Hoshino A, Kanegane H, Abukawa D, Kure S. J Clin Immunol; 2017 Jan 29; 37(1):67-79. PubMed ID: 27747465 [Abstract] [Full Text] [Related]
32. Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations. Levine AE, Zheng HB, Suskind DL. Paediatr Drugs; 2022 May 29; 24(3):207-216. PubMed ID: 35467244 [Abstract] [Full Text] [Related]
33. Dynamics of the Stool Virome in Very Early-Onset Inflammatory Bowel Disease. Liang G, Conrad MA, Kelsen JR, Kessler LR, Breton J, Albenberg LG, Marakos S, Galgano A, Devas N, Erlichman J, Zhang H, Mattei L, Bittinger K, Baldassano RN, Bushman FD. J Crohns Colitis; 2020 Nov 07; 14(11):1600-1610. PubMed ID: 32406906 [Abstract] [Full Text] [Related]
34. Recent advance in very early-onset inflammatory bowel disease. Shim JO. Intest Res; 2019 Jan 07; 17(1):9-16. PubMed ID: 30419637 [Abstract] [Full Text] [Related]
35. Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations. Shim JO, Seo JK. J Hum Genet; 2014 Jun 07; 59(6):337-41. PubMed ID: 24785691 [Abstract] [Full Text] [Related]
36. Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study. Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P, SIGENP IBD Working Group. United European Gastroenterol J; 2019 Jul 07; 7(6):759-766. PubMed ID: 31316780 [Abstract] [Full Text] [Related]
37. Recent Advance in Very Early Onset Inflammatory Bowel Disease. Shim JO. Pediatr Gastroenterol Hepatol Nutr; 2019 Jan 07; 22(1):41-49. PubMed ID: 30671372 [Abstract] [Full Text] [Related]
38. Very-early-onset Inflammatory Bowel Disease in an Infant with a Partial RIPK1 Deletion. Tuna Kırsaçlıoğlu C, Frohne A, Kuloğlu Z, Kristofersdottir I, Demir E, Altuntaş C, Haskoloğlu ZŞ, Çobanoğlu FN, Kendirli T, Özdemir H, Özçakar ZB, Savaş B, Doğu F, İkincioğulları A, Boztug K, Kansu A. J Clin Immunol; 2024 Apr 27; 44(5):108. PubMed ID: 38676845 [Abstract] [Full Text] [Related]
39. Early Onset Inflammatory Bowel Disease Due to Immunodeficiency as a Result of ICOS Gene Homozygous Mutation. Arsoy HA, Hafızoğlu D, Terzi HZ, Turhan EI. Fetal Pediatr Pathol; 2024 Apr 27; 43(5):419-425. PubMed ID: 39129221 [Abstract] [Full Text] [Related]
40. Very-Early Onset Chronic Active Colitis with Heterozygous Variants in LRBA1 and CARD11, a Case of "Immune TOR-Opathies". He M, Wong A, Sutton K, Gondim MJB, Samson C. Fetal Pediatr Pathol; 2023 Apr 27; 42(2):297-306. PubMed ID: 35748740 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]